Channel profile image
Talks (7525)
Still risks from COVID 4 pts on B cellRx
Apr 09
FDA approval of ipi/nivo for dMMR CRC
Apr 08
THC Guidelines from ACP
Apr 08
Anti-CD19 for IgG4!!!!!
Apr 07
channeling bias for safety/new BDMARDS
Apr 07
FREE LIVE WORLD CLASS IMMUNOLOGY CME
Apr 07
tovecimig meets primary endpoint in BTC
Apr 02
IBS Pathophysiology-6
Apr 02
IBS Pathophysiology-5
Apr 02
IBS Pathophysiology-4
Apr 02
IBS Pathophysiology-3
Apr 02
IBS Pathophysiology-2
Apr 02
IBS Pathophysiology-1
Apr 02
Mepolizumab EGPA Long Term !
Apr 01
IBS Rome IV criteria
Apr 01
IBS Symptoms
Apr 01
CRCDiet_10
Mar 31
CRCDiet_9
Mar 31
CRCDiet_8
Mar 31
CRCDiet_7
Mar 31
CRCDiet_6
Mar 31
CRCDiet_5
Mar 31
CRCDiet_4
Mar 31
CRCDiet_3
Mar 31
CRCDiet_2
Mar 31
CRCDiet_1
Mar 31
CRC screening-10
Mar 30
CRC screening-9
Mar 30
CRC screening-8
Mar 30
CRC screening-7
Mar 30
CARIBStrial_10
Mar 29
CARIBStrial_9
Mar 29
CARIBStrial_8
Mar 29
CARIBStrial_7
Mar 29
CARIBStrial_6
Mar 29
CARIBStrial_5
Mar 29
CARIBStrial_4
Mar 29
CARIBStrial_3
Mar 29
CARIBStrial_2
Mar 29
CARIBStrial_1
Mar 29
Enterochromaffin cells, IBS, Isovalerate
Mar 28
IBS, Motility, and Infection
Mar 28
IBS and Muscularis Macrophages
Mar 28
FODMAP Digestive Enzymes
Mar 28
Low FODMAP, Hypermobility, and IBS
Mar 28
CRC-10 - Targeted Therapy
Mar 28
IBS and hypermobility
Mar 28
Visceral Hyperalgesia
Mar 28
Visceral vs. Somatic Nervous System
Mar 28
Enterochromaffin Cells and IBS
Mar 28
CRC-9 - Targeted Therapy
Mar 28
GI Pain and Distention
Mar 28
CRC-8 - Watch and Wait for Rectal Cancer
Mar 28
CRC-7 - Rectal Cancer – TNT
Mar 28
CRC-6 - MSI-H/dMMR and Immunotherapy
Mar 28
CRC-5 - Tumor Sidedness
Mar 28
CRC-4 - Management of Metastatic CRC
Mar 28
CRC-3 - Adjuvant Chemotherapy Duration
Mar 28
CRC-2 - Stage I–III
Mar 28
cabozantinib new FDA approval for NET
Mar 28
Loading logo